Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyquaternium-1 (Polyquad) is a synthetic polymeric quaternary ammonium preservative widely used in ophthalmic solutions, including artificial tears, contact lens disinfectants, and some antiglaucoma formulations. It was developed as a less cytotoxic alternative to benzalkonium chloride, due to its larger size and hydrophilic nature, which limit penetration into mammalian cells. Polyquad exhibits effective antimicrobial activity, especially against bacteria and fungi, by disrupting their membranes. Although generally well tolerated and less toxic to the ocular surface compared to older preservatives, some in vitro and clinical studies report mild cytotoxic effects on ocular cells, particularly with frequent or prolonged use. Polyquad is not a therapeutic target but rather a pharmaceutical excipient; it does not act as or interact with biological macromolecules in a manner typical of pharmacological targets[1][3][5][6][7][8].
Not applicable as a drug target; acts as a preservative by disrupting microbial cell membranes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyquaternium-1 (PQ).